Content about Steven Collis

April 26, 2013
Walgreens, Alliance Boots, AmerisourceBergen deal to benefit Good Neighbor Pharmacy

AmerisourceBergen's base of 3,452 independently owned Good Neighbor Pharmacies will be another benefactor out of the wholesaler's blockbuster agreement with Walgreens and Alliance Boots, AmerisourceBergen CEO, president, director and chairman Steven Collis told analysts during a conference call Thursday.

VALLEY FORGE, Pa. — AmerisourceBergen's base of 3,452 independently owned Good Neighbor Pharmacies will be another benefactor out of the wholesaler's blockbuster agreement with Walgreens and Alliance Boots, AmerisourceBergen CEO, president, director and chairman Steven Collis told analysts during a conference call Thursday.

March 19, 2013
Walgreens, Alliance Boots announce blockbuster partnership with AmerisourceBergen

Walgreens will no longer source branded prescription medicines directly from suppliers beginning in September, the Chicago-based retailer announced as part of a significant partnership between Walgreens, Alliance Boots and AmerisourceBergen that includes Walgreens and Alliance Boots potentially taking a 7% stake in the Pennsylvania wholesaler.

DEERFIELD, Ill. — Walgreens will no longer source branded prescription medicines directly from suppliers beginning in September, the Chicago-based retailer announced Tuesday as part of a significant partnership between Walgreens, Alliance Boots and AmerisourceBergen that includes Walgreens and Alliance Boots potentially taking a 7% stake in the Pennsylvania wholesaler. Walgreens will begin sourcing generic medicines from AmerisourceBergen beginning in the calendar year 2014.  

January 24, 2013
ABC Q1 2013 revenue up 6%

AmerisourceBergen on Thursday reported revenue of $21.5 billion, up 5.7%, for the first quarter ended Dec. 31.

VALLEY FORGE, Pa. — AmerisourceBergen on Thursday reported revenue of $21.5 billion, up 5.7%, for the first quarter ended Dec. 31. “We are off to a solid start in our fiscal year 2013, with December quarter results in line with our expectations,” said Steven Collis, ABC president and CEO. “During the quarter, we successfully implemented our previously announced new contract with our largest customer, and we continued to make progress on the integration of World Courier.

November 1, 2012
AmerisourceBergen reports $80 billion in fiscal 2012 revenue, looking to divest AndersonBrecon

AmerisourceBergen on Thursday reported revenue dropped 0.6% to $79.5 billion for its fiscal 2012 ended Sept. 30.

VALLEY FORGE, Pa. — AmerisourceBergen on Thursday reported revenue dropped 0.6% to $79.5 billion for its fiscal 2012 ended Sept. 30. Diluted earnings per share were a record $2.76, up 10% over the prior fiscal year diluted earnings per share from continuing operations. Gross profit was up 6.7% to $2.7 billion.

October 29, 2012
AmerisourceBergen fills new chief strategy officer post

AmerisourceBergen on Monday named Lawrence Marsh, 52, to the new role of chief strategy officer and SVP new market development, effective Nov. 12, 2012.

VALLEY FORGE, Pa. — AmerisourceBergen on Monday named Lawrence Marsh, 52, to the new role of chief strategy officer and SVP new market development, effective Nov. 12, 2012. 

July 27, 2012
AmerisourceBergen Specialty Group revenues up 8%; key growth driver

AmerisourceBergen on Thursday reported that in its fiscal-year third quarter ended June 30, diluted earnings per share were 71 cents, an 8% increase over the prior-year quarter.

VALLEY FORGE, Pa. — AmerisourceBergen on Thursday reported that in its fiscal-year third quarter ended June 30, diluted earnings per share were 71 cents, an 8% increase over the prior-year quarter.

AmerisourceBergen's Specialty Group had another strong quarter with revenues up 8%, driven by another particularly strong performance in third-party logistics and in the company's vaccine and physician distribution business. Specialty Group represents significant opportunity for the wholesaler, Steven Collis, AmerisourceBergen president and CEO, told analysts.

May 11, 2012
AmerisourceBergen's acting CFO offered full-time gig

AmerisourceBergen has promoted one of its executives to serve as its finance chief, the company said Friday.

VALLEY FORGE, Pa. — AmerisourceBergen has promoted one of its executives to serve as its finance chief, the company said Friday.

Tim Guttman — who has served as acting CFO since February, as well as VP and corporate controller for the last 10 years — has been appointed SVP and CFO, effective immediately. Guttman will report to AmerisourceBergen's president and CEO Steven Collis.

Guttman replaced Michael DiCandilo, who left his role as EVP and CFO of the company earlier this year to pursue other interests.

April 26, 2012
AmerisourceBergen attributes growth to specialty biz

AmerisourceBergen on Thursday reported revenue of $20.1 billion, up 1.6%, for its second quarter ended March 31.

VALLEY FORGE, Pa. — AmerisourceBergen on Thursday reported revenue of $20.1 billion, up 1.6%, for its second quarter ended March 31.

March 6, 2012
ABC acquires World Courier Group, a biopharmaceutical logistics company

AmerisourceBergen on Tuesday announced that it has signed a definitive agreement to purchase World Courier Group, a privately held global specialty transportation and logistics provider for the biopharmaceutical industry, for $520 million in cash.

VALLEY FORGE, Pa. — AmerisourceBergen on Tuesday announced that it has signed a definitive agreement to purchase World Courier Group, a privately held global specialty transportation and logistics provider for the biopharmaceutical industry, for $520 million in cash.

February 13, 2012
AmerisourceBergen EVP, CFO steps down

AmerisourceBergen on Monday announced that Michael DiCandilo, the company's EVP and CFO, has left the company to pursue other interests, effective immediately.

VALLEY FORGE, Pa. — AmerisourceBergen on Monday announced that Michael DiCandilo, the company's EVP and CFO, has left the company to pursue other interests, effective immediately.

January 27, 2012
AmerisourceBergen reports $20.4 billion in Q1 revenue

AmerisourceBergen on Thursday reported $20.4 billion in revenue for the first quarter ended Dec. 31, up 2%.

VALLEY FORGE, Pa. — AmerisourceBergen on Thursday reported $20.4 billion in revenue for the first quarter ended Dec. 31, up 2%.

“We are off to a good start in our fiscal year 2012, with December quarter results in line with our expectations and excellent progress being made on the integration of our recent acquisitions,” stated Steven Collis, AmerisourceBergen president and CEO. “We continued to demonstrate expense and working capital discipline, and our balance sheet remains strong, giving us outstanding financial flexibility.”

November 2, 2011
ABC posts 3% revenue gain with $80.2 billion in sales

AmerisourceBergen on Tuesday recorded revenues of $20.4 billion for fourth quarter 2011 ended Sept. 30, up 3.5%. Diluted earnings per share increased 8% to 54 cents. For the year, AmerisourceBergen posted $80.2 billion in revenue, up 2.9%.

VALLEY FORGE, Pa. — AmerisourceBergen on Tuesday recorded revenues of $20.4 billion for fourth quarter 2011 ended Sept. 30, up 3.5%. Diluted earnings per share increased 8% to 54 cents. For the year, AmerisourceBergen posted $80.2 billion in revenue, up 2.9%.

July 5, 2011
Collis succeeds Yost as CEO of AmerisourceBergen

David Yost officially handed the reins of AmerisourceBergen to Steven Collis, who was named president and CEO on Friday, as Yost prepares for retirement.

VALLEY FORGE, Pa. — David Yost officially handed the reins of AmerisourceBergen to Steven Collis, who was named president and CEO on Friday, as Yost prepares for retirement.

April 4, 2011
David Neu named ABDC president

AmerisourceBergen on Monday promoted David Neu, 53, to president of AmerisourceBergen Drug, the company's largest operating unit, effective immediately. Neu, a 29-year veteran of the company, most recently was SVP operations.

VALLEY FORGE, Pa. — AmerisourceBergen on Monday promoted David Neu, 53, to president of AmerisourceBergen Drug, the company's largest operating unit, effective immediately. Neu, a 29-year veteran of the company, most recently was SVP operations.

The role of president of AmerisourceBergen Drug previously was held by Steven Collis, currently EVP and COO. Collis recently was named to succeed David Yost as CEO upon Yost's retirement on July 1. In his new role, Neu will continue to report to Steven Collis.

March 14, 2011
Yost leaves helm of AmerisourceBergen

AmerisourceBergen Monday afternoon announced that CEO David Yost will retire from the wholesaler, effective July 1, after 37 years with the company and the last 14 as CEO.

VALLEY FORGE, Pa. — AmerisourceBergen Monday afternoon announced that CEO David Yost will retire from the wholesaler, effective July 1, after 37 years with the company and the last 14 as CEO.

Yost will be succeeded by Steven Collis, 49.

October 11, 2010
Drug distribution group elects new leaders

Kicking off a new leadership era for its top industry trade group, pharmaceutical wholesalers elected...